[PMID: 8516245] PubMed record related to this compound for laboratory literature review
He mentioned, "There hasn't been a notable opposition from our members in challenging these items, possibly because they don't meet the criteria under 503A." According to Section 503A of the Food, Drug & Cosmetic Act, an eligible bulk drug substance for compounding must be a component of an FDA-approved drug, must have a USP or NF monograph, or must appear on the FDAs 503A Bulks List or Interim Bulks List Category 1
A cosmetic ingredient being legally used in skincare products does not mean it has FDA drug approval
Storage and Stability Guidelines for BPC-157 and TB-500 Lyophilized Research Peptides Research Notice: This article covers research on TB-500 research peptide and BPC-157 research peptide available from Palmetto Peptides for laboratory use only
It is more stable, longer-lasting and clinically superior to cyanocobalamin a cheaper synthetic form widely used in beauty salons and non-medical clinics that contains a small amount of cyanide which the body must detoxify